Showing results (1001-1010 of 7,009) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinomaMartyna Filipska, Marcin Skrzypski, Katarzyna Czetyrbok, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variantsYan Li, Tongtong Zhang, Jing Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapyBarbara A Helfrich, Dexiang Gao, Paul A Bunn
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinomaPierre Serra, Arthur Petat, Jean-Michel Maury, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinumWei-Yu Liao, Chao-Chi Ho, Tzu-Hsiu Tsai, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Anti-tumoral activity of the human-specific duplicated form of α7-nicotinic receptor subunit in tobacco-induced lung cancer progressionJosé Luis Cedillo, Anna Bordas, Francisco Arnalich, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancerMatthew J Schuchert, Daniel P Normolle, Omar Awais, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapyKazuki Takada, Kenichi Kohashi, Mototsugu Shimokawa, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumabCharlotte Mauclet, Fabrice Duplaquet, Lionel Pirard, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer modelsKyoung Ho Pyo, Jae Hwan Kim, Ji-Min Lee, et al.
Pageof 701